Healthcare provider profile · identity verified

Kelly Pope

Nurse Practitioner · BOYNTON BEACH, FL · NPI 1740322254

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	330	52
Potassium Chloride	Potassium Chloride	274	47
Pantoprazole Sodium	Pantoprazole Sodium	256	43
Amlodipine Besylate	Amlodipine Besylate	248	45
Atorvastatin Calcium	Atorvastatin Calcium	244	46
Lisinopril	Lisinopril	222	35
Furosemide	Furosemide	206	41
Losartan Potassium	Losartan Potassium	205	32
Trazodone Hcl	Trazodone Hcl	204	34
Sertraline Hcl	Sertraline Hcl	200	37
Quetiapine Fumarate	Quetiapine Fumarate	190	28
Donepezil Hcl	Donepezil Hcl	189	31
Carvedilol	Carvedilol	150	23
Gabapentin	Gabapentin	145	37
Memantine Hcl	Memantine Hcl	137	27
Rosuvastatin Calcium	Rosuvastatin Calcium	130	20
Omeprazole	Omeprazole	129	21
Doxycycline Hyclate	Doxycycline Hyclate	123	72
Metoprolol Succinate	Metoprolol Succinate	110	24
Tamsulosin Hcl	Tamsulosin Hcl	107	25
Metoprolol Tartrate	Metoprolol Tartrate	106	18
Montelukast Sodium	Montelukast Sodium	101	17
Hydrochlorothiazide	Hydrochlorothiazide	100	18
Eliquis	Apixaban	99	21
Escitalopram Oxalate	Escitalopram Oxalate	99	20
Mirtazapine	Mirtazapine	99	20
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	78	53
Acetaminophen-Codeine	Acetaminophen With Codeine	77	16
Famotidine	Famotidine	73	11
Levetiracetam	Levetiracetam	72	suppressed
Lorazepam	Lorazepam	70	20
Methenamine Hippurate	Methenamine Hippurate	69	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	66	45
Clopidogrel	Clopidogrel Bisulfate	65	15
Divalproex Sodium	Divalproex Sodium	64	suppressed
Pravastatin Sodium	Pravastatin Sodium	62	suppressed
Duloxetine Hcl	Duloxetine Hcl	61	12
Metformin Hcl	Metformin Hcl	58	14
Fluticasone Propionate	Fluticasone Propionate	57	16
Sucralfate	Sucralfate	52	suppressed
Torsemide	Torsemide	52	suppressed
Tramadol Hcl	Tramadol Hcl	50	14
Alprazolam	Alprazolam	49	suppressed
Allopurinol	Allopurinol	48	suppressed
Nifedipine Er	Nifedipine	45	suppressed
Xarelto	Rivaroxaban	45	suppressed
Mupirocin	Mupirocin	43	25
Glipizide	Glipizide	42	suppressed
Hydralazine Hcl	Hydralazine Hcl	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	33
Carbidopa-Levodopa	Carbidopa/Levodopa	40	suppressed
Clonazepam	Clonazepam	40	suppressed
Latanoprost	Latanoprost	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	38	suppressed
Nystatin	Nystatin	36	15
Scopolamine	Scopolamine	36	suppressed
Simvastatin	Simvastatin	36	suppressed
Finasteride	Finasteride	35	suppressed
Spironolactone	Spironolactone	34	suppressed
Risperidone	Risperidone	33	suppressed
Amiodarone Hcl	Amiodarone Hcl	32	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	30	suppressed
Meloxicam	Meloxicam	30	13
Alendronate Sodium	Alendronate Sodium	28	suppressed
Bupropion Xl	Bupropion Hcl	28	suppressed
Methocarbamol	Methocarbamol	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	22
Benazepril Hcl	Benazepril Hcl	27	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	27	suppressed
Baclofen	Baclofen	26	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	25	13
Diazepam	Diazepam	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	18
Temazepam	Temazepam	25	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Lacosamide	Lacosamide	24	suppressed
Lamotrigine	Lamotrigine	24	suppressed
Olanzapine	Olanzapine	24	suppressed
Diltiazem Hcl	Diltiazem Hcl	22	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Anastrozole	Anastrozole	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Valsartan	Valsartan	17	suppressed
Aripiprazole	Aripiprazole	16	suppressed
Myrbetriq	Mirabegron	16	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	14
Cholestyramine	Cholestyramine (With Sugar)	14	suppressed
Lactulose	Lactulose	14	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Meclizine Hcl	Meclizine Hcl	14	suppressed
Memantine Hcl Er	Memantine Hcl	14	suppressed
Propranolol Hcl	Propranolol Hcl	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Folic Acid	Folic Acid	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Prednisone	Prednisone	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Colchicine	Colchicine	12	suppressed
Depakote Er	Divalproex Sodium	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Fluconazole	Fluconazole	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Ibandronate Sodium	Ibandronate Sodium	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Sodium Chloride	Sodium Chloride Irrig Solution	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Cefuroxime	Cefuroxime Axetil	11	11
Dorzolamide-Timolol	Dorzolamide/Timolol/Pf	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error